Foley & Larder LLP represented TCG Crossover, lead investor.Adverum Biotechnologies has agreed to sell approximately 106.25 million shares of its common stock at a price per share of…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
